Clinical Trial Update: Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma

View source ↗

Summary

A completed clinical trial evaluating the efficacy of inhaled ciclesonide during the cold season in patients aged 12 years and older with persistent asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ciclesonide (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED